¿Importa la secuencia de tratamiento en egfr +?: Factores que deberían ser considerados

6 / 33

Chee Khoon Lee, et al. JNCI, 2017
First-line treatment of EGFR mutant NSCLC and OS:
EGFR TKIs vs CT IPD Meta-Analysis
Even in the absence of apparent lack of relative benefit of EGFR-TKI over chemotherapy for OS,
upfront EGFR-TKI treatment is still recommended for QOL improvement in these patients
• Even in the absence of apparent lack of relative benefit of
EGFR-TKI over chemotherapy for OS, upfront EGFR-TKI
treatment is still recommended for QOL improvement in
these patients